1. Home
  2. BNR vs FGL Comparison

BNR vs FGL Comparison

Compare BNR & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • FGL
  • Stock Information
  • Founded
  • BNR 2014
  • FGL 2021
  • Country
  • BNR China
  • FGL Malaysia
  • Employees
  • BNR N/A
  • FGL N/A
  • Industry
  • BNR Medical Specialities
  • FGL
  • Sector
  • BNR Health Care
  • FGL
  • Exchange
  • BNR Nasdaq
  • FGL NYSE
  • Market Cap
  • BNR 38.3M
  • FGL 25.4M
  • IPO Year
  • BNR 2020
  • FGL 2024
  • Fundamental
  • Price
  • BNR $4.59
  • FGL $0.94
  • Analyst Decision
  • BNR
  • FGL
  • Analyst Count
  • BNR 0
  • FGL 0
  • Target Price
  • BNR N/A
  • FGL N/A
  • AVG Volume (30 Days)
  • BNR 16.9K
  • FGL 284.8K
  • Earning Date
  • BNR 08-21-2025
  • FGL 07-22-2025
  • Dividend Yield
  • BNR N/A
  • FGL N/A
  • EPS Growth
  • BNR N/A
  • FGL N/A
  • EPS
  • BNR N/A
  • FGL N/A
  • Revenue
  • BNR $72,112,038.00
  • FGL $20,205,441.00
  • Revenue This Year
  • BNR $136.32
  • FGL N/A
  • Revenue Next Year
  • BNR N/A
  • FGL N/A
  • P/E Ratio
  • BNR N/A
  • FGL N/A
  • Revenue Growth
  • BNR 0.53
  • FGL N/A
  • 52 Week Low
  • BNR $2.18
  • FGL $0.66
  • 52 Week High
  • BNR $7.90
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • BNR 68.34
  • FGL N/A
  • Support Level
  • BNR $4.47
  • FGL N/A
  • Resistance Level
  • BNR $4.96
  • FGL N/A
  • Average True Range (ATR)
  • BNR 0.27
  • FGL 0.00
  • MACD
  • BNR 0.12
  • FGL 0.00
  • Stochastic Oscillator
  • BNR 80.53
  • FGL 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About FGL FOUNDER GROUP LTD

Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.

Share on Social Networks: